"Designing Growth Strategies is in our DNA"

Chronic Lower Back Pain Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Non-steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesic, Opioids, and Others), By Route of Administration (Oral, Topical, and Others), By Distribution Channel (Hospital Pharmacies and Retail & Online Pharmacies), and Regional Forecast, 2025-2032

Last Updated: June 02, 2025 | Format: PDF | Report ID: FBI100575

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 10.1% from 2025 to 2032

Unit

Value (USD billion)

Segmentation

By Drug Class

  • Non-steroidal Anti-Inflammatory Drugs
  • Antidepressants
  • Analgesic
  • Opioids
  • Others

By Route of Administration

  • Oral
  • Topical
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail & Online Pharmacies

By Region

  • North America (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region)
    • U.S.
    • Canada
  • Europe (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • 2019-2032
  • 2024
  • 2019-2023
  • 150
GET A FREE SAMPLE

    man icon
    Mail icon
Consulting Services
    How will you benefit from our consulting services ?